BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15615777)

  • 1. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
    Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
    J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation.
    Kim SE; Choi KY
    Cell Signal; 2007 Jul; 19(7):1554-64. PubMed ID: 17374561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation.
    Kim SE; Lee WJ; Choi KY
    Cell Signal; 2007 Mar; 19(3):511-8. PubMed ID: 17011750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC inhibits ERK pathway activation and cellular proliferation induced by RAS.
    Park KS; Jeon SH; Kim SE; Bahk YY; Holmen SL; Williams BO; Chung KC; Surh YJ; Choi KY
    J Cell Sci; 2006 Mar; 119(Pt 5):819-27. PubMed ID: 16478791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
    Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
    Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular localization and signaling activity of beta-catenin in migrating neural crest cells.
    de Melker AA; Desban N; Duband JL
    Dev Dyn; 2004 Aug; 230(4):708-26. PubMed ID: 15254905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP.
    Cong F; Schweizer L; Varmus H
    Development; 2004 Oct; 131(20):5103-15. PubMed ID: 15459103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
    González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
    Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting Wnt/beta-catenin signaling during gastrulation using RNA interference in mouse embryos.
    Lickert H; Cox B; Wehrle C; Taketo MM; Kemler R; Rossant J
    Development; 2005 Jun; 132(11):2599-609. PubMed ID: 15857914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
    Simon M; Grandage VL; Linch DC; Khwaja A
    Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
    Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
    Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt5b partially inhibits canonical Wnt/beta-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes.
    Kanazawa A; Tsukada S; Kamiyama M; Yanagimoto T; Nakajima M; Maeda S
    Biochem Biophys Res Commun; 2005 May; 330(2):505-10. PubMed ID: 15796911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/beta-catenin signaling regulates expression of PRDC, an antagonist of the BMP-4 signaling pathway.
    Im J; Kim H; Kim S; Jho EH
    Biochem Biophys Res Commun; 2007 Mar; 354(1):296-301. PubMed ID: 17222801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.
    Pradeep A; Sharma C; Sathyanarayana P; Albanese C; Fleming JV; Wang TC; Wolfe MM; Baker KM; Pestell RG; Rana B
    Oncogene; 2004 Apr; 23(20):3689-99. PubMed ID: 15116100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.